Stable Istotope Labelled Pertuzumab Biosimilar – Anti-ERBB2/EGFR2/CD340 mAb – Research Grade

Reference: PX-TA1058-SIL-1MG
Product nameStable Istotope Labelled Pertuzumab Biosimilar - Anti-ERBB2/EGFR2/CD340 mAb - Research Grade
SourceCAS 380610-27-5
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsOMNITARG,rhuMAB 2C4
ReferencePX-TA1058-SIL
Related ProductsPX-P3061
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
SourceCAS 380610-27-5
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-ERBB2/EGFR2/CD340(Homo sapiens) (Pertuzumab) Monoclonal Antibody

Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (subdomain II) of human epidermal growth factor receptor 2 protein (HER2). It was first used with docetaxel and another HER2-targeting monoclonal antibody trastuzumab to treat metastatic HER2-positive breast cancer. Since then, its indications have been expanded to be used as both neoadjuvant therapy and adjuvant therapy for the treatment of HER2-positive breast cancer with a high risk of recurrence.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Pertuzumab Biosimilar – Anti-ERBB2/EGFR2/CD340 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.